Interestingly, Dennison et al. (2013) found a predictive response of LDH-B expression to neoadjuvant chemotherapy, which supports the clinical evolution of LDH-B as a marker of response for breast cancer patients receiving neaoadjuvant chemotherapy. The gene discussed is LDHB; the disease is breast cancer.